Good News! Finding Out a New Specialty Drug Can Treat Lassa Fever

This article examines Good News! Finding Out a New Specialty Drug Can Treat Lassa Fever. It presents the main facts, practical implications, and key points in a clearer, easier-to-follow format.

Understanding Good News! Finding Out a New Specialty Drug Can Treat Lassa Fever

• Dengue fever outbreak, you know how to prevent it?
• Find out the mechanism of mutation of strange genes leading to breast cancer causing fever.

Lassa fever is an acute viral illness and is often fatal, with fever, occurring mainly in West Africa, often spread from infected mice.

The new findings suggest a combination of three monoclonal virus antibodies that can prevent the spread and destruction of primates and humans, and then death begins eight days later. when exposed to dangerous amounts of Lassa virus.

Previously, the virus, without any vaccine or treatment, infected hundreds of thousands of people each year and killed about 34% of infected people.

Thomas Geisbert of the University of Texas Medical Branch in Galveston said they found that new treatments were well tolerated and 100% protected from Lassa fever.

When untreated with Lassa virus, these animals begin to falter, viral symptoms in the body begin to begin on the fourth day after exposure.

Previously, monoclonal antibodies were widely used to treat cancer and autoimmune diseases and more than 45 different monoclonal antibodies were administered by the US Food and Drug Administration and the Pharmaceutical Agency. European products approved.

" Treatment with triple monoclonal antibodies that can save 100% of animals over a week after infection with Lassa virus suggests that this method could benefit patients with Lassa fever in West Africa., who often come to the clinic at the end of the disease,. "said researcher Robert Garry.

This study was published in Nature Medicine.